【Intro】Bora Pharmaceuticals

撰文新聞中心
日期2021-07-15
Bora Pharmaceuticals

Company Introduction

保瑞集團自2007年成立至今,從經銷代理、代工生產到研發製造,以國際規格的專業製藥工廠及領先全球的製造設備,將保瑞藥品成功行銷全球於100個國家,從台灣出發放眼國際讓全世界用到台灣做的藥!

委託合作
保瑞集團近年來不僅與美、法等國際品牌藥商建立長期夥伴關係、更於100個全球市場與夥伴共創雙贏銷售佳績或研發生產領先趨勢藥品,集團歡迎各類共創雙贏的合作模式。

亞洲專業製藥領導品牌
保瑞擁有台灣製藥產業的領導地位,具備研發代工世界級優良藥品的領先技術,貫徹產品的三大項堅持 : 穩定的品質、智慧的劑型和最佳的效能,讓台灣的藥業技術與國際級醫療品質同步接軌。

Bora Pharmaceuticals is a premier international CGMP CDMO specializing in complex oral solid dosage (tablet & capsules), liquids (solutions, suspensions, & nasal sprays) and semi-solids (creams & gels) pharmaceutical Rx and OTC products for late-phase Clinical through Commercial manufacturing and packaging.  Bora owns and operates three state-of-the-art CGMP manufacturing facilities (Taiwan and Canada) built to the highest international standards for manufacturing, packaging, R&D, and analytical testing. We can handle high potency compounds, solvents, flammables, and IR/SR/ER release profile products. 

Our sites deliver to more than 100 markets around the world including the US/Canada, EU, Southeast Asia, Middle East, and South and Central Americas. All sites are TAA compliant. Our packaging lines are fully serialized. At Bora, reliability, integrity, and innovation are at the core of every product we touch. That is why we are dedicated to offering reliable, personal service that begins with proactive project management and technical support, which results in consistently high-quality products and complete fulfillment of your global outsourcing goals.

Brief description of main products or services 

Currently, Bora has 3 state-of-the-art cGMP manufacturing facilities for CDMO services.
Our Taiwanese facilities are USFDA, MHRA, TFDA, Jordan FDA, and GCC (Gulf Cooperation Council).  Our Mississauga, Canada site is approved by all major regulatory agencies including FDA, Health Canada, ANVISA, EMEA, PDMA, and the Japanese Ministry of Health.  Our last FDA audits have had no findings.  What makes us unique in solid dose is our ability to handle routine to complex solid dosage forms (tablet and capsules) including immediate release, controlled/extended-release, extrusion/spheronization, beads, tray drying, solvent handling, film coating, Fluidized Coating System (Wurster), and much more. What will make us unique in semi-solids and liquids is our ability to manufacture from clinical to commercial scales with high throughput and our ability to handle solvents. The Mississauga site puts a strong emphasis on employee health, safety, and well-being along with high-level environmental sustainability programs. Bora Pharmaceuticals has been dedicated to maintaining the world-class quality standard from its beginning. Advanced quality systems, including QMS, EDMS, and ERP, are effectively utilized to ensure the highest manufacturing quality. At Bora, it is our mission to provide our customers pharmaceuticals with an unparalleled quality they expect. Bora Pharmaceuticals aligns with current industry trends to ensure growth for our future and strives to deliver more products of value for our customer’s patients.  

Key capabilities:

  • Immediate Release (IR) tablets/capsules 
  • Sustained, pulsed, modified, and delayed release (DR/ER) tablets/capsules 
  • Aqueous and Solvent Film Coating  
  • Powder, IR/ER beads, and granules filled into capsules  
  • Liquids - solutions, suspensions, & nasal sprays 
  • Semi-solids (creams & gels) in Aluminum tubes, laminate tubes, and sachets 
  • Large Scale XP Glatt Fluid Bed (GPCG 300) 
  • Extrusion/Spheronization 
  • Fixed Dose Combination (FDC) Products 
  • Solvent handling 
  • Potent compounds, hormones, and Steroids 
  • Formulation, process, and analytical development 
  • Fully serialized packaging 
  • Stability testing and storage